Caris Life Sciences, Inc. (CAI)
Health Care ยท Services-Medical Laboratories
Caris Life Sciences, Inc. (CAI) is listed on Nasdaq, where its shares have traded since June 18, 2025. SentiSense covers Caris Life Sciences, Inc. in the Health Care sector, and its Standard Industrial Classification is Services-Medical Laboratories. David Dean Halbert is its chief executive officer. The company reports 1,846 employees, and its corporate website is www.carislifesciences.com.
About Caris Life Sciences, Inc.
Caris Life Sciences Inc is a patient-centric, next-generation AI TechBio company. It develop and commercialize solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale.
Latest reported results
Caris Life Sciences, Inc. reported revenue of $263.7 million for Q2 FY2026, up 45.4% from the same period a year earlier.
Institutional ownership
In 13F filings for the quarter ended June 30, 2026, 237 institutions reported holding CAI, with 152.8 million shares worth $2.7 billion in aggregate. The largest reported holders were FMR, J. H. Whitney Equity Partners VI and Coatue Management. Of the 5 largest reported holders, 3 added shares, 1 reduced its position and 1 held its position unchanged during the quarter.
More on CAI
- CAI sentiment: whether news and social coverage of Caris Life Sciences, Inc. leans bullish or bearish, and the stories driving it.
- CAI ownership: all 237 reporting institutions, plus insider and congressional trades.
- CAI financials: revenue, net income, operating margin and free cash flow through Q2 FY2026.
SentiSense also tracks daily options readings for Caris Life Sciences, Inc.: IV rank, put/call percentile, 25-delta skew and open-interest walls.
Frequently asked questions
What does Caris Life Sciences, Inc. do?
Caris Life Sciences Inc is a patient-centric, next-generation AI TechBio company. It develop and commercialize solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale.
What sector is CAI in?
SentiSense classifies Caris Life Sciences, Inc. in the Health Care sector, and its Standard Industrial Classification is Services-Medical Laboratories.
Where does CAI stock trade?
Caris Life Sciences, Inc. (CAI) is listed on Nasdaq, where its shares have traded since June 18, 2025.
Who is the CEO of Caris Life Sciences, Inc.?
David Dean Halbert is the chief executive officer of Caris Life Sciences, Inc..